Investment Rating - The report assigns a "Buy" rating for the company, marking its first coverage [4][6]. Core Views - The company is a leading player in lens manufacturing, focusing on core business for steady growth. It has shifted from overseas OEM to developing its own brand and domestic market, enhancing its growth momentum. The product structure is evolving towards high-margin products, which is driving continuous improvement in profitability [4][6]. - The lens industry is experiencing stable global demand growth, with significant potential in China. New opportunities are emerging in myopia prevention and smart glasses [4][6]. - The company achieved revenue of 1.775 billion yuan in 2023, with a CAGR of 15.6% from 2018 to 2023, and a net profit of 327 million yuan, with a CAGR of 33.0% during the same period. In the first half of 2024, revenue reached 987 million yuan, a year-on-year increase of 17.9%, and net profit was 209 million yuan, up 31.6% year-on-year [4][6]. Summary by Sections 1. Company Overview - The company was established in 1996 and listed on the Hong Kong Stock Exchange in 2021. It has transitioned from primarily overseas OEM to focusing on its own brand and domestic market, which has created new growth drivers. The product mix is shifting towards high-margin products, enhancing profitability [4][15]. - The company has a strong manufacturing capability and is gradually increasing its focus on the domestic market and its own brand. In the first half of 2024, the domestic market accounted for 30.9% of revenue, an increase of 16.2 percentage points since 2018 [4][6][19]. 2. Industry Analysis - The global lens market is experiencing stable growth, with traditional lenses seeing significant demand from Europe and the US, while the Chinese market shows great potential. The domestic retail market for eyeglass lenses was valued at 89.06 billion yuan in 2023, with a CAGR of 4.7% from 2018 to 2023, and is expected to grow at 7.9% from 2023 to 2028 [4][6]. - The demand for myopia prevention lenses is driven by the severe myopia problem among youth, with increasing government focus on prevention. The market for defocus lenses has seen rapid growth, with sales expected to continue increasing [4][6][7]. 3. Financial Performance - The company forecasts net profits of 418 million yuan, 500 million yuan, and 593 million yuan for 2024, 2025, and 2026, respectively, with year-on-year growth rates of 27.8%, 19.6%, and 18.5% [4][6]. - The current market capitalization corresponds to PE ratios of 13.4, 11.2, and 9.4 for 2024, 2025, and 2026, respectively [4][6]. 4. Product and Market Strategy - The company has a comprehensive product SKU matrix and is enhancing its product structure. In the first half of 2024, standard lenses accounted for 79.7% of revenue, while customized lenses contributed 19.9% [4][17]. - The company is actively expanding its domestic market presence and brand development, with a significant increase in the proportion of self-owned brands [4][6][19].
康耐特光学：镜片制造领军企业，产品结构持续优化